sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure in relation to its interests in Spire Healthcare Group PLC. As of 17 October 2025, Vanguard holds 14,377,746 ordinary shares, representing 3.57% of the total shareholding. This position triggers the requirements under Rule 8.3 of the UK Takeover Code.
In addition to the shareholding, Vanguard reported a recent purchase of 2,344 shares at a price of 2.37 GBP per share. No cash-settled or stock-settled derivatives have been declared, nor other dealings or arrangements in relation to the securities of Spire Healthcare.
No other offerors or offerees are involved in this disclosure, and Vanguard confirmed no agreements or understandings regarding voting rights. This was declared on 20 October 2025 by contact Shawn Acker.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.